FDA-Approved Drugs Kill Hundreds of Thousands Annually FDA

New Post Public Reply Private Reply Replies (0) Message Board
bellsandwhistles
FDA-Approved Drugs Kill Hundreds of Thousands Annually

FDA Approved Prescription Drugs Kill Hundreds of Thousands of People Annually
July 31, 2013
By Matt Hall — Staff Writer

What if I told you hundreds of thousands of people died every single year from drugs? You wouldn’t be surprised. You’d probably think, “Well, they overdosed, or they abused them to get high, or they experimented  in a dangerous way and got what was coming to them.”

Well, the above statement about drug deaths is unfortunately true, and it’s been confirmed in a study published by Dr. Barbara Starfield  in the Journal of the American Medical Association. Over 100,000 people die every year from FDA-approved prescription drugs. This number isn’t from drugs that are prescribed by quacks, either.

This figure (100,000)  sadly comes from the number of people who die every year from FDA-approved pharmaceutical drugs prescribed properly by a licensed medical professional.

Worried yet? You should be.

Even though so many Americans are dying every single year from these drugs, t he FDA will do little to step in and make the changes necessary to stop Big Pharma and protect American lives. The wholesale massacre of Americans through prescriptions will continue just so some Big Pharma executive can keep his pockets lined and add another wing to his mansion.

How the Big Pharmaceuticals Stay Legally Immune

To know how we can fight gainst the influence of Big Pharmaceutical companies, it’s important to understand how they stay immune from legal recourse for peddling dangerous drugs.

Of course, the harm these pharmaceuticals is causing Americans is 100% legal. How does it stay this way? And how do they keep more honest medical treatments from being approved by the FDA?

The devil is in the details, or rather in the scheme that keeps big companies on top while preventing any other pharmaceutical companies from rising up. Here’s how they stay on top.

Clinical Trials: Perverting a Good Thing

The idea behind clinical trials is a good one: it’s that a new drug has to be tested out in controlled environments to prove they work and prove they aren’t dangerous to humans. However, thanks to the influence of Big Pharma, these trials are next to useless for people like you and me. The tests — which often involve long-term animal cruelty and human testing — are all funded by the pharmaceutical companies. If you were a researcher and your paycheck depended on making sure a new medicine passing a trial, what do you think you’d do?

Unfortunately, many researchers give into the pressure from their bosses and make clinical recommendations they shouldn’t, allowing dangerous drugs to make it to market.

In fact, many researchers don’t actually write their own recommendation reports, simply signing reports written by pharmaceutical company ghostwriters and passing them off as the work of the researchers.

These trials have also become incredibly expensive , keeping private individuals and small companies from being able to perform their own trials according to FDA standards. It’s a system governed by money that keeps the big people at the top and the little guys out of the picture.

Comments

Debbie Boyce Winterick:

July 31, 2013 at 7:38 pm

I stopped taking all of my prescription meds just recently after being on them for more than 12 years. (I'm 64 yrs. old.). I haven't felt this good for a long, long time. I don't know if it's all physiological or part psychological - I don't really care. It just feels right!

Camille Johnson:

August 1, 2013 at 1:40 am

I was on 5 different prescription medications, changed my diet to a more vegan style, eliminated processed foods, sugars... & lost 40 lbs. I am now on only one medication for the control of my seizures! Living healthy! Changed my lifestyle by my orders not my doc's, who only recommended more prescription drugs!

Geralyn Reed:

August 19, 2013 at 12:00 pm

seizures can be controlled naturally by the CBD's in marijuana. if you saw the special a week ago of Dr Sanjay Gupta it featured a child that suffered from 300 to 400 seizures a month , she is taking medical cannabis and is down to 1 or 2 seizures a month.

Robert Bonan:

August 25, 2013 at 6:05 am

Geralyn Reed - Yes indeed it does work. Dr Gupta's documentary video on youtube are being taken down. So if you have NOT watched it then get it now while you can and down load it. Then make DVD copies and give them away.

Elijah William Eby:

January 16, 2014 at 8:37 pm

If a drug has 1 in 10,000 chance of killing you, it is oftentimes very reasonable to take it.

Over millions and millions of people taking reasonable risks, hundreds of thousands will die.

Christi Linscott Billups:

August 18, 2013 at 9:43 pm

Absolutely the truth. A friend's sister just passed away on Friday from a prescribed drug. a side effect listed was death. Please think twice before blindly taking prescribed meds. I am considered a non-compliant patient because I refuse to take prescribed meds. I'd rather be alive and not taking them than dead from taking them.

Sherry Cook Youngs:

August 20, 2013 at 4:33 am

we've been labeled as "non-compliant" also. Out of 8 prescriptions on my shelf, I take 3. I'd rather be a little achy than have bleeding stomach

Cathy McMahan:

August 25, 2013 at 12:52 pm

Sherry Cook Youngs why don't you look into aloe vera? and there are others that heal

Deborah Dunkerton:

August 1, 2013 at 3:27 am

when my mother developed dementia I took over her care and one of the first things I did was take her off most of her medications, some were actually contradicting each other. then I worked out the main reason she had developed dementia (quite suddenly) was the fact she was on three statin medications. Don't take statins folks, they rot your brain.

Jacqueline LaRose Nusz:

August 18, 2013 at 8:34 pm

No artificial sweeteners either!

Molly Thomas:

August 26, 2013 at 3:05 am

third after heart disease I believe.

Gary V Brookes:

August 1, 2013 at 3:03 pm

Wow, I heard BILL GATES say there are too many people on the planet, I wayched him say this with my own two eyes. My issue is, I never knew the plan to decrease the population was already in full effect? Learn how some folks are protecting themselves from this problem
Natasha Khubeis:

August 1, 2013 at 9:58 pm

It's disgusting! I guess it's population control. They want you to live until retirement then they would have no need for you anymore. They would prefer you go before. You start collecting your pension. Scary but true

Jacqueline LaRose Nusz:

August 18, 2013 at 8:36 pm

Whoever it is, wants to kill off us "baby boomers"!

Geralyn Reed:

August 19, 2013 at 12:08 pm

straight herbs are much better than homeopathic. Big Pharma spreads poison, one only needs to listen to the advertisements and all the side effects to realize that they are the ones spewing the poison and useless drugs. Most just cause more side effects that need more big pharma it is a vicious cycle and most end up taking way too many drugs. Neil you stated that most who die from prescription drugs are already very ill, (hmm you don't suppose they are very ill due to the drugs they are taking? ) and most drug deaths don't occur in hospitals, duh! the occur in the home. Medical Cannabis, goldenseal, and a few other carefully chosen medicinal herbs can cure much more than any prescription drug ever will and without all the side effects.


Neil Murrell:

October 12, 2013 at 5:47 pm

Terrie Smith - Apologies for this late reply. I forgot to check the thread. I'm sorry to hear you've had so many problems, but I'm glad to hear the neuro-stimulator seems to be working for you. I had a 2 week trial with a similar device for a different condition and it didn't work at all, so I'm well aware that what may work for one person may not for another. You certainly seem like a very prudent consumer, and, of course, everyone should aspire to take as much care with their medication as you do. And it's also true that there are a great many people who find natural therapies very helpful. For instance, my condition means I used to get a lot of water infections, but since I started drinking cranberry juice every day I've been (almost) completely free of them. Sorry if my other post came off as a bit short-tempered. I think the tone of the article got under my skin a bit (phrases like "medical massacre" didn't help) and I might have wrongly given the impression that I don't have time for ANY alternative therapies. That's not what I meant to say. I do, admittedly, have a rather dim view of homeopathy but by and large I do agree that in quite a lot of cases there is indeed a midde ground between different therapies. All the best.

Christine Johnson Hanses:

July 31, 2013 at 9:10 pm

I'm working on getting rid of mine but there are only 2 to eliminate.. and working on both 1 for allergies and 1 for thyroid. so still working on it! also eliminating the products with gmo's in them so that's got to be helping! If this is correct.... then who really killed Micheal Jackson? interesting thought!

Mary Cookie Holley:

Bob Rose:

August 25, 2013 at 4:12 pm

I have a health issue (stage 2 squamous cell carcinoma. I don't have health insurance. My responsibility. I inquired about clinical trials and believe it or not was told that I would have to pay for the drugs. I was so thrilled that I could be a guinea pig , risk permanent harm with no success, and the best part get to pay for it. WOO HOO! NOT! Until my issue started (diagnosed about 2 months ago ) I've been turned down by 5 hospitals. Was also told in order to receive Medicaid I would have to apply for disability. Big medicine= big business. No profit= no care. They can't make any money off of you if you're healthy or dead.
http://www.undergroundhealth.com/fda-approved...-annually/

SK3 Group Inc. (SKTO) Stock Research Links

SKTO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Epsilor Launches Cutting-Edge 6T Battery for Military Use

Updated Category News Views 1

A Big Leap for Military Power on the Go Seems like Epsilor just raised the stakes in the military tech race with their latest 6T battery, a piece of kit boasting some serious muscle at 4,400Wh with 174Ah thrown in for good measure. Serving up a military-grade solution where endurance and performance are necessities, they've entered production just in time for the...

Continue Reading
STANLEY Dives Into Flooring: Strategic Move or Risky Bet?

Updated Category News Views 3

STANLEY® Floors: The New Frontier? Who would've thought STANLEY®, the tool giant founded back in 1843, would dive headfirst into the flooring market? This isn’t just any leap; it's a strategic handshake with Area Floors, and they’re dragging along i4F’s renowned drop-lock tech for good measure. What does this mean for the flooring landscape and STANLEY's brand...

Continue Reading
Vanda Pharmaceuticals Steps Into September Investor Talks

Updated Category News Views 2

Vanda Pharmaceuticals Heads Into Key Investor Spotlights In the relentless quest for market edge, Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is setting the stage for what could be some telling moments in September 2026. Investors with a keen interest in the pharmaceutical realm should seat themselves upfront as Vanda takes the floor in a series of pivotal conferences. Each...

Continue Reading
Codoxo Snags 2026 Award for AI Payment Innovation

Updated Category News Views 1

Revolutionizing Healthcare Payment with AI Ah, healthcare and payments—two things that can make even the most patient folks lose their cool. But here comes Codoxo, shaking up this landscape with its Point Zero Payment Integrity solution, and someone's finally giving them the nod they deserve. For those of us who have been in the game for a while, this announcement is...

Continue Reading
Epson and STOPware Reinvent Visitor Badges for Security

Updated Category News Views 12

Gone are the days when a flimsy monochrome badge was all that stood between a visitor and unrestricted access. Today, Epson and STOPware rock the boat with their new collaboration, offering a game-changing approach to security with full-color badge printing. This isn't just a vanity upgrade; it's about real security enhancement creating immediate visual cues. Shifting the...

Continue Reading
Corgi Re Modernizes Reinsurance with Tech-Focus

Updated Category News Views 2

Amidst the hullabaloo of the reinsurance world, Corgi Insurance is attempting something rather bold. They're flinging open the doors to innovation with a new brainchild, Corgi Re, promising to shake off the dust from an industry that still clings to the bygone era of spreadsheets and marathon underwriting cycles. The aim? Fire up modern underwriting technology and...

Continue Reading
Tolnai Joins UPCEA Leaders Pioneering Credential Innovations

Updated Category News Views 1

The Future of Education Shaped Today There's a profound shift happening in higher education, and it's not the usual undergrad grind most folks think of. Cate Tolnai, stepping into her role at the University of Phoenix, is in the thick of it. She's set to join the UPCEA Council for Credential Innovation's leadership team, and that isn't some fluff title. Her appointment...

Continue Reading
Mega Matrix Shares Consolidation Ahead: What It Means

Updated Category News Views 1

Quick and Unexpected Moves at Mega Matrix Just when you thought things couldn't get more complicated in the world of Mega Matrix Inc. (NYSE: MPU), they pull a rabbit out of the hat at their Extraordinary General Meeting on September 1st. Held at their office in Singapore, shareholders green-lighted some heavy-hitting changes like a share consolidation—twenty into one...

Continue Reading
Check Point Shareholders Back 2026 AGM Proposals

Updated Category News Views 0

Shareholder Endorsement Solidifies Check Point's Strategy Today, Check Point Software Technologies had a bit of a celebratory mood. Their stakeholders, it seems, aren't just riding the wave; they're all in. You could almost hear the cheers from Redwood City when those shareholder voting results flashed across the board. Some 81.2 million shares—encompassing about 79.52%...

Continue Reading
Costa Rica's Summit Draws Global Investors, Buyers

Updated Category News Views 0

Costa Rica's Big Stage for Business and Opportunity You might look at Costa Rica and think of lush rainforests and coffee beans, but right now, it's a hub bustling with suits, spreadsheets, and strategic meetings. Over three days, the Costa Rica Trade & Investment Summit (CRTIS) gathered nearly half a thousand buyers and investors all under one roof in San José. Local...

Continue Reading

Top 5 Most Recently Viewed Articles

BlackRock Moves Past 3% Stake in Syensqo, Notifications Issued

Updated Category News Views 186

BlackRock Inc. Participation Notification for Syensqo In a noteworthy development, BlackRock Inc. has recently communicated to Syensqo its participation status under Belgian transparency regulations, signaling a significant movement in their share ownership. The company has crossed the crucial 3% threshold, which triggers a notification requirement. Here’s a...

Continue Reading
Exploring the Bullish Trends in D-Wave Quantum's Options Trades

Updated Category News Views 262

Understanding D-Wave Quantum's Options Activity Recently, notable investors have exhibited a strong bullish sentiment towards D-Wave Quantum, signaling confidence in its future performance. When analyzing the options history for D-Wave Quantum (NYSE: QBTS), we identified a total of 21 trades. This activity reveals the mindset of investors which could be crucial for future...

Continue Reading
ECN Capital Moves Forward with Share Buyback Initiatives

Updated Category News Views 67

ECN Capital's Strategic Buyback Plans Approved ECN Capital Corp. (TSX: ECN) has recently received approval from the Toronto Stock Exchange (TSX) to begin normal course issuer bids for its common shares and Series C preferred shares. This strategic decision is aimed at effectively managing the company's equity structure while optimizing its cash resources. Understanding...

Continue Reading
Understanding Recent Updates on Cellectis Voting Rights

Updated Category News Views 130

Significant Updates on Cellectis Share Capital Cellectis is currently navigating through exciting timelines that focus on share capital and voting rights. As a prominent player in the gene editing industry, the company strives diligently to engage with its shareholders and keep them informed about the specifics of its capital structure. Market Listing and Share Details...

Continue Reading
Mallinckrodt plc Reports Strong Q3 Performance and Upgraded Guidance

Updated Category News Views 36

Mallinckrodt plc Financial Highlights Mallinckrodt plc, a global leader in specialty pharmaceuticals, has recently announced its financial outcome for the third quarter of the current fiscal year, demonstrating continued resilience and growth. With net sales reaching $505.5 million, marking a 1.7% increase compared to the same quarter last year, the company has reaffirmed...

Continue Reading